Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Implant endosseous root-form

OsseoSpeed EV 3.0 S - 13 mm: medical device reports filed with FDA

460 reports name it, 2019–2026. Manufacturer given most often on reports: Dentsply Implants Manufacturing. Product code DZE.

460
device reports naming the brand
0% of all MAUDE reports · about 65 a year
105
reports, 12 months to August 2026
101 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

460 medical device reports received by FDA name the brand "OsseoSpeed EV 3.0 S - 13 mm" (implant endosseous root-form); the manufacturer given most often on reports is Dentsply Implants Manufacturing; received from June 2019 to July 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

105 reports arrived in the 12 months to August 2026, close to the 101 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (56.1%), osseointegration problem (32.2%) and loss of osseointegration (10.4%). The patient problems coded most often are failure of implant, inflammation and osteolysis. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

0918Sep 2021: 2Oct 2021: 1Nov 2021: 5Dec 2021: 12022Jan 2022: 5Feb 2022: 5Mar 2022: 2Apr 2022: 4May 2022: 1Jun 2022: 3Jul 2022: 2Aug 2022: 3Sep 2022: 2Oct 2022: 4Nov 2022: 2Dec 2022: 42023Jan 2023: 4Feb 2023: 9Mar 2023: 2Apr 2023: 1May 2023: 3Jun 2023: 1Jul 2023: 0Aug 2023: 3Sep 2023: 2Oct 2023: 5Nov 2023: 1Dec 2023: 12024Jan 2024: 4Feb 2024: 6Mar 2024: 5Apr 2024: 7May 2024: 6Jun 2024: 5Jul 2024: 1Aug 2024: 13Sep 2024: 4Oct 2024: 10Nov 2024: 5Dec 2024: 32025Jan 2025: 15Feb 2025: 3Mar 2025: 16Apr 2025: 1May 2025: 2Jun 2025: 10Jul 2025: 14Aug 2025: 18Sep 2025: 14Oct 2025: 11Nov 2025: 10Dec 2025: 52026Jan 2026: 17Feb 2026: 4Mar 2026: 11Apr 2026: 11May 2026: 7Jun 2026: 5Jul 2026: 10Aug 2026: 0

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

0621242019: 1420192021: 12420212022: 3720222023: 3220232024: 6920242025: 11920252026: 652026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%460
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report100%460
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate25856.1%62.8%
Osseointegration problem14832.2%7.7%
Loss of osseointegration4810.4%22.4%
Off-label use459.8%0%
Fracturea broken bone71.5%1.6%
Loosening of implant not related to bone-ingrowth30.7%0.1%
Fluid/blood leak10.2%0%
Improper or incorrect procedure or method10.2%0%
Malposition of device10.2%0.1%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Failure of implant460100%
Inflammationinflammation398.5%
Osteolysis194.1%
Pocket erosion102.2%
Fistula10.2%
Implant pain10.2%
Purulent discharge10.2%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureOsseoSpeed EV 3.0 S - 13 mmProduct code DZEAll MAUDE reports
Reports4603,924,24126,136,888
Share of that pool—0%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer100%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about OsseoSpeed EV 3.0 S - 13 mm reports

How many FDA reports name OsseoSpeed EV 3.0 S - 13 mm?

460 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 105 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (56.1%), osseointegration problem (32.2%), loss of osseointegration (10.4%), off-label use (9.8%) and fracture (1.5%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that OsseoSpeed EV 3.0 S - 13 mm was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.